Tag: UTULY (BRYN-NDS1C)

neffy®

FDA Denies Approval of Needle-Free Alternative to Epinephrine Auto-injectors

The rejection was unexpected based on feedback from the FDA's expert panel in June.
Bryn Pharma Intranasal Epinephrine Device

Bryn Pharma Raises Another $15 Million for Commercialization of Needle-Free Intranasal...

Company is developing UTULY for intranasal emergency epinephrine delivery.
Bryn Pharma Intranasal Epinephrine Device

Bryn Shows UTULY™ Intranasal Epinephrine Absorbs Faster and is Sustained Longer...

A needleless, self administered nasal spray intended to be used in anaphylactic emergencies in place of traditional auto-injectors.
Bryn Pharma Intranasal Epinephrine Device

Bryn Pharma Completes Study of Nasal Epinephrine vs Auto-Injector for Anaphylaxis

Nasal administration of epinephrine takes another step forward.
Needless Epinephrine Alternatives

They’re Coming: Needle-Free Emergency Epinephrine Options Currently in Trials

For some, the needle is a barrier to administration but alternatives are on the horizon.
Neffy Intranasal Epinephrine Device

CEO Expects Approval and Launch of Intranasal Emergency Epinephrine Spray by...

The market for epinephrine delivery may expand to include non-needle alternatives next year.
Intranasal Spray

Intranasal Epinephrine to Take Center Stage at 2022 AAAAI Annual Meeting

Emergency epinephrine without the jab makes strides.
Bryn Pharma Intranasal Epinephrine Device

Bryn Pharma Research on Epinephrine Nasal Spray Presented at ACAAI Annual...

Two studies shed light on the viability of intranasal delivery of emergency epinephrine.